Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Kapadia S, Patrawalla A. Extrapulmonary tuberculosis presenting as a cavernous sinus syndrome: Case report with review of existing literature. IDCases. 2014;1(4):97-100. doi: 10.1016/j.idcr.2014.10.010. eCollection 2014. PubMed PMID: 26839786; PubMed Central PMCID: PMC4735080.
Kapadia SN, Abramson EL, Carter EJ, Loo AS, Kaushal R, Calfee DP, Simon MS. The Expanding Role of Antimicrobial Stewardship Programs in Hospitals in the United States: Lessons Learned from a Multisite Qualitative Study. Jt Comm J Qual Patient Saf. 2018 Feb;44(2):68-74. doi: 10.1016/j.jcjq.2017.07.007. Epub 2018 Jan 2. PubMed PMID: 29389462.
Kapadia SN, Jeng PJ, Schackman BR, Bao Y. State Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting Antivirals. Clin Infect Dis. 2018 May 2;66(10):1618-1620. doi: 10.1093/cid/cix1062. PubMed PMID: 29206910; PubMed Central PMCID: PMC6248367.
Kapadia SN, Singh HK, Jones S, Merrick S, Vaamonde CM. Missed Opportunities for HIV Testing of Patients Tested for Sexually Transmitted Infections at a Large Urban Health Care System From 2010 to 2015. Open Forum Infect Dis. 2018 Jul;5(7):ofy165. doi: 10.1093/ofid/ofy165. eCollection 2018 Jul. PubMed PMID: 30087904; PubMed Central PMCID: PMC6059204.
Kapadia SN, Marks KM. Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers. Clin Ther. 2018 Aug;40(8):1234-1245. doi: 10.1016/j.clinthera.2018.05.010. Epub 2018 Jul 5. PubMed PMID: 29983266; PubMed Central PMCID: PMC6448786.
Kapadia SN, Grant RR, German SB, Singh B, Davidow AL, Swaminathan S, Hodder S. HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens. SAGE Open Med. 2018;6:2050312118816919. doi: 10.1177/2050312118816919. eCollection 2018. PubMed PMID: 30574301; PubMed Central PMCID: PMC6295695.
Kapadia SN, Wu C, Mayer KH, Wilkin TJ, Amico KR, Landovitz RJ, Andrade A, Chen YQ, Chege W, McCauley M, Gulick RM, Schackman BR. No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305. PLoS One. 2018;13(12):e0206577. doi: 10.1371/journal.pone.0206577. eCollection 2018. PubMed PMID: 30586364; PubMed Central PMCID: PMC6306196.
Bhagwat P, Kapadia SN, Ribaudo HJ, Gulick RM, Currier JS. Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy. Open Forum Infect Dis. 2019 Feb;6(2):ofz022. doi: 10.1093/ofid/ofz022. eCollection 2019 Feb. PubMed PMID: 30793009; PubMed Central PMCID: PMC6372057.
Kapadia SN, Johnston CD, Marks KM, Schackman BR, Martin EG. Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity. J Public Health Manag Pract. 2019 May/Jun;25(3):245-252. doi: 10.1097/PHH.0000000000000829. PubMed PMID: 29927900; PubMed Central PMCID: PMC6309344.
Kapadia SN, Bao Y. Prescription painkiller misuse and the perceived risk of harm from using heroin. Addict Behav. 2019 Jun;93:141-145. doi: 10.1016/j.addbeh.2019.01.039. Epub 2019 Jan 28. PubMed PMID: 30711666; PubMed Central PMCID: PMC6488411.
Ding T, Song T, Zhou B, Geber A, Ma Y, Zhang L, Volk M, Kapadia SN, Jenkins SG, Salvatore M, Ghedin E. Microbial Composition of the Human Nasopharynx Varies According to Influenza Virus Type and Vaccination Status. mBio. 2019 Jul 2;10(4). doi: 10.1128/mBio.01296-19. PubMed PMID: 31266874; PubMed Central PMCID: PMC6606809.
Hirschfeld CB, Kapadia SN, Bryan J, Jannat-Khah DP, May B, Vielemeyer O, Esquivel EL. Impact of diagnostic bone biopsies on the management of non-vertebral osteomyelitis: A retrospective cohort study. Medicine (Baltimore). 2019 Aug;98(34):e16954. doi: 10.1097/MD.0000000000016954. PubMed PMID: 31441894; PubMed Central PMCID: PMC6716736.
Katzman C, Mateu-Gelabert P, Kapadia SN, Eckhardt BJ. Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination. Int J Drug Policy. 2019 Oct;72:33-39. doi: 10.1016/j.drugpo.2019.04.003. Epub 2019 Apr 19. PubMed PMID: 31010750; PubMed Central PMCID: PMC6717536.
Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. J Subst Abuse Treat. 2019 Nov;106:79-88. doi: 10.1016/j.jsat.2019.08.010. Epub 2019 Aug 14. PubMed PMID: 31540615.
Kapadia SN, Gulick RM. Drug Costs: What Can Infectious Diseases Physicians Do?. J Infect Dis. 2020 Feb 18;221(5):681-684. doi: 10.1093/infdis/jiz067. PubMed PMID: 30887031; PubMed Central PMCID: PMC7325612.
Kapadia SN, Johnson P, Schackman BR, Bao Y. Hepatitis C Treatment Uptake by New Prescribers After the Introduction of Direct Acting Antivirals. J Gen Intern Med. 2020 Mar;35(3):975-977. doi: 10.1007/s11606-019-05200-6. PubMed PMID: 31325131; PubMed Central PMCID: PMC7080943.
Rendeiro AF, Casano J, Kyriakos Vorkas C, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chiu S, Cappelli L, Teresa Cacciapuoti M, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G. Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression. medRxiv. 2020 Sep 9;. doi: 10.1101/2020.09.08.20189092. PubMed PMID: 32935114; PubMed Central PMCID: PMC7491529.
Zhang H, Tallavajhala S, Kapadia SN, Jeng PJ, Shi Y, Wen H, Bao Y. State Opioid Limits and Volume of Opioid Prescriptions Received by Medicaid Patients. Med Care. 2020 Dec;58(12):1111-1115. doi: 10.1097/MLR.0000000000001411. PubMed PMID: 32925468; PubMed Central PMCID: PMC7808343.
Kapadia SN, Katzman C, Fong C, Eckhardt BJ, Guarino H, Mateu-Gelabert P. Hepatitis C testing and treatment uptake among young people who use opioids in New York City: A cross-sectional study. J Viral Hepat. 2021 Feb;28(2):326-333. doi: 10.1111/jvh.13437. Epub 2020 Nov 22. PubMed PMID: 33141503; PubMed Central PMCID: PMC8207521.
Rendeiro AF, Casano J, Vorkas CK, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chiu S, Cappelli LV, Cacciapuoti MT, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Life Sci Alliance. 2021 Feb;4(2). doi: 10.26508/lsa.202000955. Print 2021 Feb. PubMed PMID: 33361110; PubMed Central PMCID: PMC7768198.
Butt AA, Yan P, Kapadia S, Abou-Samra AB, Janjua NZ, Ibrahim S. Social vulnerability in persons with chronic hepatitis C virus infection is associated with a higher risk of prescription opioid use. Sci Rep. 2021 Mar 15;11(1):5883. doi: 10.1038/s41598-021-85283-6. PubMed PMID: 33723313; PubMed Central PMCID: PMC7961056.
Fong C, Mateu-Gelabert P, Ciervo C, Eckhardt B, Aponte-Melendez Y, Kapadia S, Marks K. Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City. Drug Alcohol Depend. 2021 Apr 1;221:108589. doi: 10.1016/j.drugalcdep.2021.108589. Epub 2021 Feb 13. PubMed PMID: 33621804; PubMed Central PMCID: PMC8029599.
Behrends CN, Kapadia SN, Schackman BR, Frimpong JA. Addressing Barriers to On-site HIV and HCV Testing Services in Methadone Maintenance Treatment Programs in the United States: Findings From a National Multisite Qualitative Study. J Public Health Manag Pract. 2021 Jul-Aug 01;27(4):393-402. doi: 10.1097/PHH.0000000000001262. PubMed PMID: 33346582; PubMed Central PMCID: PMC8137509.
Kapadia SN, Griffin JL, Waldman J, Ziebarth NR, Schackman BR, Behrends CN. A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study. J Gen Intern Med. 2021 Jul;36(7):1898-1905. doi: 10.1007/s11606-020-06409-6. Epub 2021 Jan 19. PubMed PMID: 33469774; PubMed Central PMCID: PMC7815286.
Kapadia SN, Johnson P, Marks KM, Schackman BR, Bao Y. Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era. Med Care. 2021 Sep 1;59(9):795-800. doi: 10.1097/MLR.0000000000001573. PubMed PMID: 34081676; PubMed Central PMCID: PMC8384709.
Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Arnold DM. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nat Med. 2021 Nov;27(11):2012-2024. doi: 10.1038/s41591-021-01488-2. Epub 2021 Sep 9. PubMed PMID: 34504336; PubMed Central PMCID: PMC8604729.
Aponte-Melendez Y, Mateu-Gelabert P, Fong C, Eckhardt B, Kapadia S, Marks K. The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services. Harm Reduct J. 2021 Nov 24;18(1):118. doi: 10.1186/s12954-021-00568-3. PubMed PMID: 34819070; PubMed Central PMCID: PMC8611635.
Kapadia SN, Griffin JL, Waldman J, Ziebarth NR, Schackman BR, Behrends CN. The Experience of Implementing a Low-Threshold Buprenorphine Treatment Program in a Non-Urban Medical Practice. Subst Use Misuse. 2022;57(2):308-315. doi: 10.1080/10826084.2021.2012484. Epub 2021 Dec 10. PubMed PMID: 34889691; PubMed Central PMCID: PMC8862128.
Stoeckle K, Witting B, Kapadia S, An A, Marks K. Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir. J Med Virol. 2022 Jan;94(1):384-387. doi: 10.1002/jmv.27280. Epub 2021 Aug 23. PubMed PMID: 34406670; PubMed Central PMCID: PMC8426873.
Rendeiro AF, Vorkas CK, Krumsiek J, Singh HK, Kapadia SN, Cappelli LV, Cacciapuoti MT, Inghirami G, Elemento O, Salvatore M. Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment. Front Immunol. 2021;12:809937. doi: 10.3389/fimmu.2021.809937. eCollection 2021. PubMed PMID: 35095900; PubMed Central PMCID: PMC8790058.
Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15. PubMed PMID: 34910859; PubMed Central PMCID: PMC8693692.
Behrends CN, Lu X, Corry GJ, LaKosky P, Prohaska SM, Glick SN, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. Drug Alcohol Depend. 2022 Mar 1;232:109323. doi: 10.1016/j.drugalcdep.2022.109323. Epub 2022 Jan 20. PubMed PMID: 35124386; PubMed Central PMCID: PMC8772135.
Eckhardt B, Mateu-Gelabert P, Aponte-Melendez Y, Fong C, Kapadia S, Smith M, Edlin BR, Marks KM. Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial. JAMA Intern Med. 2022 May 1;182(5):494-502. doi: 10.1001/jamainternmed.2022.0170. PubMed PMID: 35285851; PubMed Central PMCID: PMC8922207.
Eckhardt B, Kapadia SN, Mateu-Gelabert P, Pai M, Fong C, Aponte-Melendez Y, Marks KM. Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial. Open Forum Infect Dis. 2022 Jul;9(7):ofac225. doi: 10.1093/ofid/ofac225. eCollection 2022 Jul. PubMed PMID: 35821731; PubMed Central PMCID: PMC9272437.
Fanucchi LC, Murphy SM, Surratt H, Kapadia SN, Walsh SL, Grubbs JA, Thornton AC, Nuzzo P, Lofwall MR. Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections. Ther Adv Infect Dis. 2022 Jan-Dec;9:20499361221108005. doi: 10.1177/20499361221108005. eCollection 2022 Jan-Dec. PubMed PMID: 35847566; PubMed Central PMCID: PMC9277431.
Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Responding to a surge in overdose deaths: perspectives from US syringe services programs. Harm Reduct J. 2022 Jul 19;19(1):79. doi: 10.1186/s12954-022-00664-y. PubMed PMID: 35854351; PubMed Central PMCID: PMC9295104.
Mateu-Gelabert P, Sabounchi NS, Guarino H, Ciervo C, Joseph K, Eckhardt BJ, Fong C, Kapadia SN, Huang TTK. Hepatitis C virus risk among young people who inject drugs. Front Public Health. 2022;10:835836. doi: 10.3389/fpubh.2022.835836. eCollection 2022. PubMed PMID: 35968435; PubMed Central PMCID: PMC9372473.
Eckhardt B, Aponte-Melendez Y, Kapadia SN, Mateu-Gelabert P. Contact tracing in acute hepatitis C: The source patient identification and group overlap therapy proof-of-concept pilot program. Clin Liver Dis (Hoboken). 2022 Aug;20(2):72-76. doi: 10.1002/cld.1242. eCollection 2022 Aug. PubMed PMID: 36033428; PubMed Central PMCID: PMC9405500.
Tabatabaeepour N, Morgan JR, Jalali A, Kapadia SN, Meinhofer A. Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder. J Subst Abuse Treat. 2022 Sep;140:108800. doi: 10.1016/j.jsat.2022.108800. Epub 2022 May 10. PubMed PMID: 35577664; PubMed Central PMCID: PMC9357143.
Epstein RL, Wang J, White LF, Kapadia SN, Morgan JR, Bao Y, Linas BP. Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured. Am J Prev Med. 2022 Sep;63(3):e87-e98. doi: 10.1016/j.amepre.2022.03.010. Epub 2022 Jun 18. PubMed PMID: 35725599; PubMed Central PMCID: PMC9676070.
King M, Kapadia SN. A Review of Infectious Diseases Guidelines' Incorporation of Economic Evidence. Clin Infect Dis. 2022 Sep 30;75(7):1269-1270. doi: 10.1093/cid/ciac357. Review. PubMed PMID: 35512134; PubMed Central PMCID: PMC10233266.
Des Jarlais DC, Behrends CN, Corcorran MA, Glick SN, Perlman DC, Kapadia SN, Lu X, Feelemyer J, LaKosky P, Prohaska SM, Schackman BR. Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021. Public Health Rep. 2022 Nov-Dec;137(6):1066-1069. doi: 10.1177/00333549221120241. Epub 2022 Sep 16. PubMed PMID: 36113105; PubMed Central PMCID: PMC9574299.
Finbråten AK, Eckhardt BJ, Kapadia SN, Marks KM. Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples. Gastroenterol Hepatol (N Y). 2022 Nov;18(11):628-638. PubMed PMID: 36866028; PubMed Central PMCID: PMC9972665.
Austin EJ, Corcorran MA, Briggs ES, Frost MC, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Jarlais DCD, Williams EC, Glick SN. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives. Int J Drug Policy. 2022 Nov;109:103825. doi: 10.1016/j.drugpo.2022.103825. Epub 2022 Aug 10. PubMed PMID: 35977459; PubMed Central PMCID: PMC9364718.
Kapadia SN, Eckhardt BJ, Leff JA, Fong C, Mateu-Gelabert P, Marks KM, Aponte-Melendez Y, Schackman BR. Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial. Drug Alcohol Depend Rep. 2022 Dec;5. doi: 10.1016/j.dadr.2022.100109. Epub 2022 Oct 7. PubMed PMID: 36644226; PubMed Central PMCID: PMC9836210.
Corcorran MA, Austin EJ, Behrends CN, Briggs ES, Frost MC, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine. J Addict Med. 2023 Jan-Feb 01;17(1):e36-e41. doi: 10.1097/ADM.0000000000001036. Epub 2022 Aug 2. PubMed PMID: 35916422; PubMed Central PMCID: PMC9892351.
Ude M, Behrends CN, Kelly S, Schackman BR, Clear A, Goldberg R, Gelberg K, Kapadia SN. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study. Harm Reduct J. 2023 Feb 2;20(1):12. doi: 10.1186/s12954-023-00742-9. PubMed PMID: 36732773; PubMed Central PMCID: PMC9893960.
Kapadia SN, Zhang H, Gonzalez CJ, Sen B, Franco RA, Shapiro MF, Bao Y. Specialist and Primary Care Treatment of Hepatitis C Infections in US Medicaid in 2018. J Gen Intern Med. 2023 Apr;38(5):1323-1325. doi: 10.1007/s11606-022-07860-3. Epub 2022 Nov 2. PubMed PMID: 36323823; PubMed Central PMCID: PMC10110770.
Kapadia SN, Aponte-Melendez Y, Rodriguez A, Pai M, Eckhardt BJ, Marks KM, Fong C, Mateu-Gelabert P. "Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City. Harm Reduct J. 2023 Jul 27;20(1):95. doi: 10.1186/s12954-023-00831-9. PubMed PMID: 37501180; PubMed Central PMCID: PMC10375754.
Kapadia SN, Zhang H, Gonzalez CJ, Sen B, Franco R, Hutchings K, Wethington E, Talal A, Lloyd A, Dharia A, Wells M, Bao Y, Shapiro MF. Hepatitis C Treatment Initiation Among US Medicaid Enrollees. JAMA Netw Open. 2023 Aug 1;6(8):e2327326. doi: 10.1001/jamanetworkopen.2023.27326. PubMed PMID: 37540513; PubMed Central PMCID: PMC10403776.
What would you like to do?